Table 9.6b

Immunosuppression Used for Maintenance Prior to Discharge, 1994 to 2003

Recipients with Liver Transplants

		Year of Transplant
		1994	1995	1996	1997	1998	1999	2000	2001	2002	2003
Functioning Graft at Discharge		3,062	3,345	3,438	3,583	3,932	4,098	4,327	4,576	4,791	5,152
With Immunosuppression Info		3,052	3,313	3,325	3,430	3,745	3,940	4,310	4,571	4,788	5,106
Corticosteroids	Category Usage	90.8%	88.2%	91.7%	94.9%	94.5%	92.9%	91.8%	90.2%	90.3%	82.4%
	Steroids	90.8%	88.2%	91.7%	94.9%	94.5%	92.9%	91.8%	90.2%	90.3%	82.4%
Cyclosporine	Category Usage	64.4%	47.1%	40.9%	38.3%	31.1%	25.8%	18.5%	11.9%	10.2%	8.5%
	Cyclosporin	62.3%	39.7%	4.9%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Sandimmmune	2.2%	3.1%	6.7%	4.3%	4.0%	3.8%	3.1%	1.3%	1.1%	0.4%
	Neoral	1.4%	5.9%	30.3%	34.8%	27.3%	22.3%	15.5%	9.6%	7.4%	7.2%
	Gengraf	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.7%	1.5%	0.8%
	Eon	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.4%	0.2%	0.1%
Tacrolimus	Category Usage	30.7%	47.4%	55.4%	59.0%	67.1%	71.6%	76.5%	83.1%	86.8%	89.0%
	FK506	30.7%	47.4%	55.4%	59.0%	67.1%	71.6%	76.5%	83.1%	86.8%	89.0%
Antimetabolites	Category Usage	48.1%	42.0%	48.5%	43.4%	42.0%	44.5%	48.2%	50.6%	51.6%	57.2%
	Azathioprine	47.1%	35.8%	26.1%	19.0%	11.6%	7.6%	5.0%	3.0%	3.5%	3.2%
	Mycophenolate mofetil	0.9%	6.2%	22.9%	26.8%	30.8%	37.3%	43.4%	47.6%	48.0%	54.1%
	Leflunomide	0.0%	0.0%	0.0%	0.0%	0.1%	0.1%	0.0%	0.0%	0.0%	0.0%
	Cytoxan	0.4%	0.3%	0.2%	0.2%	0.2%	0.2%	0.1%	0.1%	0.1%	0.0%
Other	Category Usage	0.0%	0.0%	0.1%	0.0%	0.8%	0.5%	9.4%	9.9%	6.6%	4.3%
	Rapamycin	0.0%	0.0%	0.1%	0.0%	0.8%	0.5%	9.4%	9.9%	6.6%	4.3%

Source: OPTN/SRTR Data as of May 3, 2004.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.